National Drug Code (NDC) Database
Bora Pharmaceutical Services Inc.
-
NDC:
53873-086
-
Nonproprietary Name:
Carvedilol Phosphate
-
Dosage Form:
CAPSULE, EXTENDED RELEASE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
80 mg/1
-
Substance:
CARVEDILOL PHOSPHATE
-
Start Marketing Date:
2022-11-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
BRACCO IMAGING SPA
-
NDC:
57876-333
-
Nonproprietary Name:
gadobenate dimeglumine
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
GADOBENATE DIMEGLUMINE
-
Start Marketing Date:
2004-11-23
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Breckenridge Pharmaceutical, Inc.
-
NDC:
51991-001
-
Nonproprietary Name:
Terbinafine Hydrochloride
-
Dosage Form:
TABLET
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
250 mg/1
-
Substance:
TERBINAFINE HYDROCHLORIDE
-
Start Marketing Date:
2023-10-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Breckenridge Pharmeceutical, Inc.
-
NDC:
51991-995
-
Nonproprietary Name:
OMEPRAZOLE
-
Dosage Form:
CAPSULE, DELAYED RELEASE PELLETS
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
20 mg/1
-
Substance:
OMEPRAZOLE
-
Start Marketing Date:
2023-03-27
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Brichem Sciences Private Limited
-
NDC:
87456-014
-
Nonproprietary Name:
Testosterone Cypionate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
100 g/100g
-
Substance:
TESTOSTERONE CYPIONATE
-
Start Marketing Date:
2026-03-03
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CIII
-
Certified Through:
2027-12-31
BrightGene Bio-Medical Technological Co., Ltd.
-
NDC:
62227-702
-
Nonproprietary Name:
Selamectin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
SELAMECTIN
-
Start Marketing Date:
2024-12-12
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
BrightGene Bio-Medical Technology Co., Ltd.
-
NDC:
62227-028
-
Nonproprietary Name:
Cabergoline
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
10 g/10g
-
Substance:
CABERGOLINE
-
Start Marketing Date:
2026-01-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Bristol-Myers Squibb Company
-
NDC:
70409-7126
-
Nonproprietary Name:
RELATLIMAB
-
Dosage Form:
INJECTION
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
RELATLIMAB
-
Start Marketing Date:
2011-12-19
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
BSP Pharmaceuticals S.p.A.
-
NDC:
43624-043
-
Nonproprietary Name:
Polatuzumab Vedotin lyophilized vials 140 mg
-
Dosage Form:
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
140 mg/7.52mL
-
Substance:
POLATUZUMAB VEDOTIN
-
Start Marketing Date:
2019-06-10
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
BSP Pharmaceuticals SpA
-
NDC:
43624-038
-
Nonproprietary Name:
Multiple-Dose Tirzepatide Injection
-
Dosage Form:
INJECTION, SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
15 mg/.6mL
-
Substance:
TIRZEPATIDE
-
Start Marketing Date:
2025-11-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.